DZIF researchers develop vaccines against the Ebola virus and against MERS corona. New active substances raise hopes in the fight against multidrug-resistant bacteria. Find out more about current research topics in our press releases.
Talking to researchers
All our research projects are run by interesting personalities who are committed to their projects, and contribute new developments to help advance medicine. Find out more about the people working at the DZIF.
Images and brochures
Why are so many infection researchers committed to the DZIF? Who are the people behind this nationwide research association? You can find interviews, photos, annual reports and brochures in our Media Centre.
Do you need a contact person for a specific infection research topic? We have DZIF experts for almost every infectious disease topic, be it concerning bacterial, viral or fungal infections. Contact us; we will try to connect you.
The DZIF and its objectives
In 2012, the DZIF was founded as an affiliation of 32 university and non-university research establishments by the BMBF, in order to advance translational infection research in Germany. But what is its mission and what are its objectives?
Press mailing list
At the DZIF, around 250 scientists in 35 member establishments research exiting topics in the field of infection research. Be it Ebola, hospital pathogens, emerging viruses or gastrointestinal infections—we promptly report the results. If you would like to receive current press releases, please write a short email with your name and e-mail address to our Press Office.
Karola Neubert – Public Relations Officer
E-MAIL PHONE +49 531 6181 1170